Treating blood pressure (BP) alone may provide only limited benefits while it is recommendable to manage the total cardiovascular risk. To date, several studies have shown that concomitant treatment of hypertension and dyslipidemia with non-pharmacological approaches and/or metabolically neutral antihypertensive drugs and statins produce a significantly greater reduction of the risk of developing cardiovascular disease. Thus, in this review article, we summarize the available evidence regarding non-pharmacological and pharmacological approaches with a favourable effect on both BP and lipids.
Borghi C, F.F. (2022). Hypertension and Dyslipidemia Combined Therapeutic Approaches. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 29(3), 221-230 [10.1002/ptr.7536].
Hypertension and Dyslipidemia Combined Therapeutic Approaches.
Borghi C
Primo
Conceptualization
;Agnoletti DWriting – Original Draft Preparation
;Cicero AFG.Ultimo
Supervision
2022
Abstract
Treating blood pressure (BP) alone may provide only limited benefits while it is recommendable to manage the total cardiovascular risk. To date, several studies have shown that concomitant treatment of hypertension and dyslipidemia with non-pharmacological approaches and/or metabolically neutral antihypertensive drugs and statins produce a significantly greater reduction of the risk of developing cardiovascular disease. Thus, in this review article, we summarize the available evidence regarding non-pharmacological and pharmacological approaches with a favourable effect on both BP and lipids.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.